4-hydroxyandrostenedione – further clinical and extended endocrine observations

The Effect of an Aromatase Inhibitor, 4-Hydroxy-4-Androstene- 3,17-Dione, On Estrogen-Dependent Processes in Reproduction and Breast Cancer¹¹

Angela Brodie, William C. Schwarzel, Abubakar A. Shaikh et al. · Endocrinology · 1977 · 367 citations

Medicine, Endocrinology, Oncology +17

Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route.

Mitch Dowsett, Paul E. Goss, TJ Powles et al. · PubMed · 1987 · 240 citations

Medicine, Oncology, Pharmacology +17

4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER

R. Charles Coombes, Mitch Dowsett, Paul E. Goss et al. · The Lancet · 1984 · 235 citations

Medicine, Oncology, Pharmacology +10

Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.

P. A. Goss, TJ Powles, Mitch Dowsett et al. · PubMed · 1986 · 216 citations

Medicine, Oncology, Pharmacology +13

Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients.

Mitch Dowsett, David Cunningham, Robert C. Stein et al. · PubMed · 1989 · 141 citations

Pharmacy, Pharmacokinetics, Pharmacology +17